Study provides the first data on leadless pacemakers in a pediatric population in a real-world setting.

Using 3D imaging, researchers in the Cardiac Center at Children’s Hospital of Philadelphia (CHOP) have found that patients with hypoplastic left heart syndrome (HLHS) experiencing moderate to severe tricuspid regurgitation (TR) have structural differences in their tricuspid valve.

Two research teams in CHOP’s Cardiac Center have been awarded research grants to study single ventricle congenital heart disease.

Cardiac Center researchers present their findings at Cardiology 2023 in Rio Grande, Puerto Rico.

On Sunday, March 12, hundreds of patient families, friends, clinicians, donors, and sponsors rode for little hearts at the seventh annual Philly Spin-In benefiting Children’s Hospital of Philadelphia’s (CHOP) Cardiac Center.

Dr. Callahan discusses his interest in PVS and his hopes for CHOP’s new program.

Researchers in CHOP’s Pediatric Heart Valve Center have found that the neurotransmitter serotonin can adversely affect the heart’s mitral valve, contributing to a heart disease known as degenerative mitral regurgitation.

An NIH-funded study showed those with a history of MIS-C had mild reactions to the vaccine, with no diagnosis of myocarditis or recurrent MIS-C.

Meet Matthew O’Connor, MD, Medical Director of the Heart Failure and Transplant Program at Children’s Hospital of Philadelphia (CHOP).

Members of the Cardiac Center’s Family Advisory Council share their main takeaways after attending Cardiology 2022.